Total Pancreatectomy in a Patient Treated with a Sensor-augmented Pump Showing No Evidence of Hyperglycemia or Ketoacidosis without Any Insulin Administration

Intern Med. 2024 Apr 15;63(8):1125-1130. doi: 10.2169/internalmedicine.1920-23. Epub 2023 Sep 1.

Abstract

Total pancreatectomy results in complete loss of insulin and glucagon. Sensor-augmented pumps (SAPs) allow fine-tuning of the basal insulin rate, which helps avoid both hypo- and hyperglycemic events. We herein report a case of total pancreatectomy treated with a SAP with no evidence of ketoacidosis without any insulin administration during a certain period of time. Furthermore, we observed a sudden drop in blood glucose levels without insulin, which may have been due to glucose effectiveness. Our case is valuable in arguing the concept of glucose effectiveness in the absence of insulin and glucagon.

Keywords: glucagon; glucose effectiveness; insulin; pancreatectomy; sensor augmented pump.

Publication types

  • Case Reports

MeSH terms

  • Blood Glucose
  • Diabetes Mellitus, Type 1* / drug therapy
  • Glucagon / therapeutic use
  • Glucose
  • Humans
  • Hyperglycemia* / drug therapy
  • Hyperglycemia* / etiology
  • Hypoglycemic Agents / therapeutic use
  • Insulin / therapeutic use
  • Insulin Infusion Systems
  • Ketosis*
  • Pancreatectomy

Substances

  • Glucagon
  • Blood Glucose
  • Insulin
  • Glucose
  • Hypoglycemic Agents